The committee organized a core group in 2001 to address issues
of specific concern to the pharmaceutical sector. Thus far, the
group has concentrated on the following areas:
Raising quality standards to international levels; encouraging
the development of know-how and the transfer of product quality
testing to Egypt
Cooperation to strengthen research & development capabilities;
encouraging local companies to invest in R&D through incentives
or strategic alliances with multinational corporations
Improving understanding of intellectual property rights (IPR)
in the Egyptian market; communicate implications and methods of
implementation throughout the industry and to the public
Initiate dialogue between the US and Egyptian regulatory authorities;
enhance the regulatory and legal framework based on the application
of clear, transparent guidelines